Mechanical and repeated antimicrobial therapy using a local drug delivery system in the treatment of peri-implantitis: a randomized clinical trial

Peri-implantitis is an inflammatory process caused by microorganisms affecting the tissues around an osseointegrated implant in function, resulting in a loss of supporting bone. Limited data exist regarding the treatment of peri-implantitis. The aim of this study was to assess the clinical and micro...

Full description

Saved in:
Bibliographic Details
Published inJournal of periodontology (1970) Vol. 79; no. 5; p. 836
Main Authors Renvert, Stefan, Lessem, Jan, Dahlén, Gunnar, Renvert, Helena, Lindahl, Christel
Format Journal Article
LanguageEnglish
Published United States 01.05.2008
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Peri-implantitis is an inflammatory process caused by microorganisms affecting the tissues around an osseointegrated implant in function, resulting in a loss of supporting bone. Limited data exist regarding the treatment of peri-implantitis. The aim of this study was to assess the clinical and microbiologic outcome of repeated local administration of minocycline microspheres, 1 mg, in cases of peri-implantitis. Thirty-two subjects with at least one implant with a probing depth > or =4 mm combined with bleeding and/or exudate on probing and the presence of putative pathogenic bacteria were included in the study. At baseline, subjects were randomly assigned to receive local minocycline microspheres (17 subjects and 57 implants) or chlorhexidine gel (15 subjects and 38 implants) following debridement. Treatments were performed on three occasions: baseline and days 30 and 90. Follow-up examinations were conducted at 10 days and at 1, 3, 6, 9, and 12 months. The use of minocycline resulted in significant improvements in probing depths compared to chlorhexidine at days 30, 90, and 180 (P = 0.5, P = 0.01, and P = 0.04, respectively). For the deepest sites of the minocycline-treated implants, the mean probing depth reduction was 0.6 mm at 12 months. Regarding bleeding on probing, significant differences between groups, based on all four sites at the implants, were found at days 30, 90, 180, 270, and 360. Both treatments resulted in a marked reduction in the indicator bacteria. The use of a repeated local antibiotic as an adjunct to the mechanical treatment of peri-implantitis lesions demonstrated improvements in probing depths that were significantly different from controls and were sustained for 6 months. The adjunctive use of minocycline microspheres is beneficial in the treatment of peri-implant lesions, but the treatment may have to be repeated.
AbstractList Peri-implantitis is an inflammatory process caused by microorganisms affecting the tissues around an osseointegrated implant in function, resulting in a loss of supporting bone. Limited data exist regarding the treatment of peri-implantitis. The aim of this study was to assess the clinical and microbiologic outcome of repeated local administration of minocycline microspheres, 1 mg, in cases of peri-implantitis. Thirty-two subjects with at least one implant with a probing depth > or =4 mm combined with bleeding and/or exudate on probing and the presence of putative pathogenic bacteria were included in the study. At baseline, subjects were randomly assigned to receive local minocycline microspheres (17 subjects and 57 implants) or chlorhexidine gel (15 subjects and 38 implants) following debridement. Treatments were performed on three occasions: baseline and days 30 and 90. Follow-up examinations were conducted at 10 days and at 1, 3, 6, 9, and 12 months. The use of minocycline resulted in significant improvements in probing depths compared to chlorhexidine at days 30, 90, and 180 (P = 0.5, P = 0.01, and P = 0.04, respectively). For the deepest sites of the minocycline-treated implants, the mean probing depth reduction was 0.6 mm at 12 months. Regarding bleeding on probing, significant differences between groups, based on all four sites at the implants, were found at days 30, 90, 180, 270, and 360. Both treatments resulted in a marked reduction in the indicator bacteria. The use of a repeated local antibiotic as an adjunct to the mechanical treatment of peri-implantitis lesions demonstrated improvements in probing depths that were significantly different from controls and were sustained for 6 months. The adjunctive use of minocycline microspheres is beneficial in the treatment of peri-implant lesions, but the treatment may have to be repeated.
Author Lindahl, Christel
Renvert, Helena
Dahlén, Gunnar
Renvert, Stefan
Lessem, Jan
Author_xml – sequence: 1
  givenname: Stefan
  surname: Renvert
  fullname: Renvert, Stefan
  email: stefan.renvert@hv.hkr.se
  organization: Department of Health Sciences, Kristianstad University, Kristianstad, Sweden. stefan.renvert@hv.hkr.se
– sequence: 2
  givenname: Jan
  surname: Lessem
  fullname: Lessem, Jan
– sequence: 3
  givenname: Gunnar
  surname: Dahlén
  fullname: Dahlén, Gunnar
– sequence: 4
  givenname: Helena
  surname: Renvert
  fullname: Renvert, Helena
– sequence: 5
  givenname: Christel
  surname: Lindahl
  fullname: Lindahl, Christel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18454662$$D View this record in MEDLINE/PubMed
BookMark eNo1kMtOwzAQRb0oog9Ys0P-gZSJ4zg2O1TxkorYwLqyE7t1FSeW4yCFz-CLcVVYja5m5pzRLNGs6zuN0E0O61wAuTv2fk0A-BoqKGg1QwsAQrKCCjJHy2E4ppjTAi7RPOe0pIyRBfp50_VBdraWLZZdg4P2WkbdpBCts3XolU2teNBB-gmPg-32WOK2Py00YdzjRrf2S4cJD9MQtcO2O03jGBLH6S7i3mCvg82s8-2JGu1wnxAh6Xpnv5Orbu35ghiS7ApdGNkO-vqvrtDn0-PH5iXbvj-_bh62WV1WwLKiqJjgTBWGGs6l4KVhkpRM5MCB50YxIiWosmIN5FQRylVTFYIZZUolKCUrdHvm-lE53ex8sE6Gaff_HPIL3hxpJw
CitedBy_id crossref_primary_10_1111_j_1600_051X_2009_01443_x
crossref_primary_10_1902_jop_2015_150464
crossref_primary_10_1002_cre2_286
crossref_primary_10_1111_cid_70010
crossref_primary_10_1016_j_jdent_2024_104980
crossref_primary_10_1007_s10103_014_1692_3
crossref_primary_10_1186_s40064_016_1735_2
crossref_primary_10_1155_2014_487903
crossref_primary_10_1563_aaid_joi_D_17_00261
crossref_primary_10_1097_ID_0000000000000846
crossref_primary_10_1002_bem_22481
crossref_primary_10_1111_j_1600_0501_2010_02124_x
crossref_primary_10_3390_molecules26185661
crossref_primary_10_1111_prd_12049
crossref_primary_10_1089_photob_2023_0109
crossref_primary_10_1007_s40406_013_0007_5
crossref_primary_10_1902_jop_2015_150476
crossref_primary_10_1007_s12285_013_0416_1
crossref_primary_10_1111_jre_12681
crossref_primary_10_1111_jcpe_12006
crossref_primary_10_1111_clr_13456
crossref_primary_10_1155_2019_9374607
crossref_primary_10_1111_j_1600_0501_2010_02098_x
crossref_primary_10_1111_j_1600_051X_2010_01561_x
crossref_primary_10_1097_ID_0000000000000681
crossref_primary_10_1111_j_1600_051X_2011_01839_x
crossref_primary_10_1097_ID_0000000000000832
crossref_primary_10_1007_s00784_015_1571_8
crossref_primary_10_3390_pharmaceutics16060769
crossref_primary_10_1002_jbm_b_31644
crossref_primary_10_1111_omi_12155
crossref_primary_10_1186_s40729_021_00388_x
crossref_primary_10_1111_jcpe_13823
crossref_primary_10_1007_s12285_013_0386_3
crossref_primary_10_4103_jips_jips_64_24
crossref_primary_10_1902_jop_2011_100660
crossref_primary_10_1097_ID_0000000000000398
crossref_primary_10_1111_jcpe_12292
crossref_primary_10_1177_0022034518818479
crossref_primary_10_1111_prd_12069
crossref_primary_10_1007_s00784_015_1406_7
crossref_primary_10_1111_j_1600_051X_2012_01908_x
crossref_primary_10_1038_sj_bdj_2014_858
crossref_primary_10_1016_j_jdent_2021_103790
crossref_primary_10_56373_2010_2_16
crossref_primary_10_1563_aaid_joi_D_22_00023
crossref_primary_10_1111_j_1600_051X_2011_01832_x
crossref_primary_10_1111_j_1600_0501_2012_02494_x
crossref_primary_10_1111_clr_13556
crossref_primary_10_4103_jdi_jdi_20_19
crossref_primary_10_1007_s00784_017_2310_0
crossref_primary_10_1111_jre_12707
crossref_primary_10_1016_j_jobcr_2020_03_012
crossref_primary_10_1111_idj_12034
crossref_primary_10_1016_j_oooo_2012_02_016
crossref_primary_10_3390_nano12244481
crossref_primary_10_3390_pharmaceutics12070668
crossref_primary_10_12968_denu_2015_42_2_166
crossref_primary_10_1563_aaid_joi_D_21_00204
crossref_primary_10_1016_j_jdent_2009_06_010
crossref_primary_10_3390_antibiotics11121766
crossref_primary_10_1111_clr_12733
crossref_primary_10_1002_14651858_CD003069_pub4
crossref_primary_10_3390_jfb15050114
crossref_primary_10_17827_aktd_1489140
crossref_primary_10_1002_JPER_20_0205
crossref_primary_10_3390_antibiotics9110835
crossref_primary_10_1111_prd_12122
crossref_primary_10_1016_j_prosdent_2024_03_024
crossref_primary_10_1111_j_1600_0501_2012_02542_x
crossref_primary_10_1007_s00784_020_03240_5
crossref_primary_10_4028_www_scientific_net_JBBTE_11_21
crossref_primary_10_4012_dmj_2021_122
crossref_primary_10_34172_japid_2022_009
crossref_primary_10_1111_j_1600_051X_2010_01540_x
crossref_primary_10_1111_clr_12686
crossref_primary_10_1111_j_2041_1626_2012_00116_x
crossref_primary_10_1111_jcpe_13773
crossref_primary_10_17795_ajdr_21610
crossref_primary_10_3390_ma14226805
crossref_primary_10_1016_j_cden_2009_08_008
crossref_primary_10_1016_j_cden_2014_08_002
crossref_primary_10_3390_antibiotics13030269
crossref_primary_10_5005_jp_journals_10042_1019
crossref_primary_10_1016_j_cden_2019_02_003
crossref_primary_10_3390_app11114985
crossref_primary_10_1002_14651858_CD004970_pub5
crossref_primary_10_1111_cid_13006
crossref_primary_10_7759_cureus_48042
crossref_primary_10_1111_j_1600_051X_2009_01421_x
crossref_primary_10_1111_clr_12155
crossref_primary_10_3390_antibiotics8020082
crossref_primary_10_1111_prd_12149
crossref_primary_10_3390_antibiotics10111298
crossref_primary_10_1111_j_1600_051X_2008_01276_x
crossref_primary_10_1111_j_1600_051X_2012_01884_x
crossref_primary_10_12968_denu_2019_46_10_986
crossref_primary_10_1007_s00284_010_9655_9
crossref_primary_10_1097_ID_0000000000000469
crossref_primary_10_1111_j_1600_051X_2011_01759_x
crossref_primary_10_1002_JPER_20_0353
crossref_primary_10_1111_idh_12002
crossref_primary_10_51479_cspzl_2023_007
crossref_primary_10_1097_ID_0000000000000869
crossref_primary_10_1902_jop_2009_090152
crossref_primary_10_1089_pho_2009_2496
crossref_primary_10_1111_cid_12624
crossref_primary_10_1111_cid_12343
crossref_primary_10_1016_j_jdent_2010_03_003
crossref_primary_10_3390_app10155376
crossref_primary_10_3390_pharmaceutics3030538
crossref_primary_10_1111_clr_12147
crossref_primary_10_1007_s00784_014_1337_8
crossref_primary_10_1007_s00784_016_2033_7
crossref_primary_10_3390_ma16082953
crossref_primary_10_1097_ID_0b013e3182263589
crossref_primary_10_1111_ors_12548
crossref_primary_10_1111_prd_12159
crossref_primary_10_3233_BME_191074
crossref_primary_10_1111_j_1600_051X_2011_01762_x
crossref_primary_10_1111_j_1600_0501_2009_01753_x
crossref_primary_10_1186_s40729_015_0023_1
crossref_primary_10_15171_jlms_2016_24
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1902/jop.2008.070347
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Dentistry
ExternalDocumentID 18454662
Genre Comparative Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-Y1
.55
0R~
1OB
1OC
33P
34H
53G
5GY
5RE
AAEUS
AAHQN
AAIPD
AAMNL
AANLZ
AAQQT
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCUV
ABDQB
ABJNI
ABLJU
ABOCM
ABQWH
ABXGK
ACAHQ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEIGN
AENEX
AEUYR
AFFNX
AFFPM
AFGKR
AFWVQ
AGHNM
AHBTC
AIACR
AITYG
AIURR
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMYDB
BFHJK
C45
CGR
CS3
CUY
CVF
CWXXS
DCZOG
DRFUL
DRMAN
DRSTM
DU5
EBS
ECM
EIF
EJD
F5P
FUBAC
GK1
HGLYW
KBYEO
L7B
LATKE
LEEKS
LUTES
LYRES
MEWTI
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
NPM
O9-
OVD
P2P
P2W
PER
RJQFR
ROL
SAMSI
SJN
SUPJJ
TEORI
UCV
UMD
USG
W99
WH7
WOHZO
WXSBR
X7M
XZL
YOJ
ZE2
ZGI
ZVN
ZZTAW
ID FETCH-LOGICAL-c5706-3376986b3f4f88a985f6a2569108081fb62aa0b576d014b248bd7396fbf5b9442
ISSN 0022-3492
IngestDate Thu Apr 03 07:06:24 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5706-3376986b3f4f88a985f6a2569108081fb62aa0b576d014b248bd7396fbf5b9442
PMID 18454662
ParticipantIDs pubmed_primary_18454662
PublicationCentury 2000
PublicationDate May 2008
PublicationDateYYYYMMDD 2008-05-01
PublicationDate_xml – month: 05
  year: 2008
  text: May 2008
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of periodontology (1970)
PublicationTitleAlternate J Periodontol
PublicationYear 2008
SSID ssj0021430
Score 2.301655
Snippet Peri-implantitis is an inflammatory process caused by microorganisms affecting the tissues around an osseointegrated implant in function, resulting in a loss...
SourceID pubmed
SourceType Index Database
StartPage 836
SubjectTerms Adult
Aged
Anti-Infective Agents, Local - administration & dosage
Bacteria - classification
Bacteria - drug effects
Chi-Square Distribution
Chlorhexidine - administration & dosage
Chlorhexidine - analogs & derivatives
Colony Count, Microbial
Combined Modality Therapy
Delayed-Action Preparations
Dental Implantation, Endosseous - adverse effects
Dental Implants - adverse effects
Dental Implants - microbiology
Dental Scaling
Female
Follow-Up Studies
Gels
Humans
Male
Microspheres
Middle Aged
Minocycline - administration & dosage
Periodontal Index
Periodontitis - drug therapy
Periodontitis - etiology
Periodontitis - microbiology
Prosthesis-Related Infections - drug therapy
Prosthesis-Related Infections - microbiology
Retreatment
Single-Blind Method
Statistics, Nonparametric
Title Mechanical and repeated antimicrobial therapy using a local drug delivery system in the treatment of peri-implantitis: a randomized clinical trial
URI https://www.ncbi.nlm.nih.gov/pubmed/18454662
Volume 79
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZSOMAF8Yby0By4RQtJ1vba3BAFKqRygFbqrbJjGxYlm1UelejP4BczfuwjoUXAZRXZ0WR359M8nJlvCHmBCY4xGKpm-YSZjNqCZoJLkbGcWy3FmKkwvu3oEz88oR9P2elg0GcI3qz1y-nFpX0l_6NVXEO9-i7Zf9BsKxQX8DPqF6-oYbz-lY6PrO_bbfv9l7ZGy2o9-eq6nJeBYsnXkkfigOEmHAuoYXBfQ7PcfB0aO_N1GT8SoXNT9NhVn_t6aHySrJzXMxXoV1exPRpdnFnMywv8tba5MkwAuSLa9VIwA67WkfPJ00PJYtQ7h_hsq_PUP_RlbV2_VGi1srGXu1s8UN9m8T_-YDU_YBiulpeICl5VbR1tiK6QsN9qQOWWuY6zZxIsWc_2isik8ptPkIFj9vuiTpWzaOMiyWcPIfU8QATTXUZ5dA9_3t0h6W629sgepit-_qo_NEp5P4ako5a0Hp8mMUzhfb3auStPYZsk7aQ5Idw5vk1uJc3Bmwi6O2Rgq7vkxoGvLfPjAe-Rnx34ALEADfhgC3yQwAcBfKAggA88-KABH0TwQVn5b0MLPlg42AXfaxTRQQ8a6EGA3n1y8v7d8dvDLA34yKas8DWX6N2k4Dp31AmhpGCOK4zBpS98FWOn-USpkcaU2GAmrydUaFPkkjvtmJaUTh6Qa9Wiso8I0NwoJ4spp9qz2I2lNIpPi0Izasea68fkYXydZ3VkcTlrXvT-lTtPyM0OlU_JdYdmwz7DGHStnwcN_wKP3IiG
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanical+and+repeated+antimicrobial+therapy+using+a+local+drug+delivery+system+in+the+treatment+of+peri-implantitis%3A+a+randomized+clinical+trial&rft.jtitle=Journal+of+periodontology+%281970%29&rft.au=Renvert%2C+Stefan&rft.au=Lessem%2C+Jan&rft.au=Dahl%C3%A9n%2C+Gunnar&rft.au=Renvert%2C+Helena&rft.date=2008-05-01&rft.issn=0022-3492&rft.volume=79&rft.issue=5&rft.spage=836&rft_id=info:doi/10.1902%2Fjop.2008.070347&rft_id=info%3Apmid%2F18454662&rft_id=info%3Apmid%2F18454662&rft.externalDocID=18454662
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3492&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3492&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3492&client=summon